Back to search
FDAFDA · Food and drugs·Recall number D-1248-2020

Daytrana (methylphenidate transdermal system) Delivers 20 mg over 9 hours (2.2 mg/hr) 30-count box, Rx only, Manufactured for Noven Therapeutics, LLC Miami, FL 33186, NDC 68968-5554-3

Published April 29, 2020 · Recall initiated: March 31, 2020

Summary

FDA records drug Class II recall D-1248-2020, published April 29, 2020 and initiated March 31, 2020. Recalling firm: Noven Therapeutics, LLC; Status: Terminated; Reported quantity: 5,614 30-count boxes; Lot: Lot: 86354 Exp. 08/2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Defective Delivery System: Out of specification for mechanical peel and shear.

What to do

Voluntary: Firm initiated · Letter

Get an email if DAYTRANA has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
DAYTRANA
Manufacturer
Noven Therapeutics, LLC
Distributor
Distributed Nationwide in the US
Lot
Lot: 86354 Exp. 08/2020
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Daytrana (methylphenidate transdermal system) Delivers 20 mg over 9 hours (2.2 mg/hr) 30-count box, Rx only, Manufactured for Noven Therapeutics, LLC Miami, FL 33186, NDC 68968-5554-3 recalled?

Yes. FDA published recall D-1248-2020 on April 29, 2020. Reported hazard: Defective Delivery System: Out of specification for mechanical peel and shear.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: DAYTRANA.